We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $110B
1-Year Est. Return 4.8%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
+2.6%
1 Year Est. Return
+4.8%
3 Year Est. Return
+123.53%
5 Year Est. Return
+125.55%
10 Year Est. Return
+1,754.37%
AUM
$191B
AUM Growth
-$14.1B
Cap. Flow
-$5.5B
Cap. Flow %
-2.88%
Top 10 Hldgs %
39.72%
Holding
509
New
38
Increased
113
Reduced
204
Closed
17

Top Buys

Rank Stock Value
1
DNA icon
Ginkgo Bioworks
DNA
+$1.11B
2
PTON icon
Peloton Interactive
PTON
+$877M
3
CPNG icon
Coupang
CPNG
+$455M
4
DASH icon
DoorDash
DASH
+$423M
5
SPOT icon
Spotify
SPOT
+$387M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$2.87B
2
TSLA icon
Tesla
TSLA
+$1.41B
3
MRNA icon
Moderna
MRNA
+$1.35B
4
AMZN icon
Amazon
AMZN
+$928M
5
NTES icon
NetEase
NTES
+$766M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 27.57%
2 Healthcare 26.02%
3 Technology 18.64%
4 Communication Services 12.04%
5 Financials 5.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSM icon
426
Williams-Sonoma
WSM
$29.6B
$13K ﹤0.01%
152
SILK
427
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$13K ﹤0.01%
235
TSP
428
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$13K ﹤0.01%
349
BRC icon
429
Brady Corp
BRC
$4.57B
$12K ﹤0.01%
245
DRI icon
430
Darden Restaurants
DRI
$24.4B
$12K ﹤0.01%
82
IRWD icon
431
Ironwood Pharmaceuticals
IRWD
$714M
$12K ﹤0.01%
935
JKHY icon
432
Jack Henry & Associates
JKHY
$11.1B
$12K ﹤0.01%
71
LBRDK icon
433
Liberty Broadband Class C
LBRDK
$5.15B
$12K ﹤0.01%
70
LCII icon
434
LCI Industries
LCII
$2.65B
$12K ﹤0.01%
86
LITE icon
435
Lumentum
LITE
$69.3B
$12K ﹤0.01%
141
-27
-16% -$2.26K
PLL
436
DELISTED
Piedmont Lithium
PLL
$12K ﹤0.01%
+212
New +$12.3K
TXRH icon
437
Texas Roadhouse
TXRH
$13.7B
$12K ﹤0.01%
131
SUMO
438
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
$12K ﹤0.01%
726
XENT
439
DELISTED
Intersect ENT, Inc
XENT
$12K ﹤0.01%
440
+79
+22% +$1.95K
BLNK icon
440
Blink Charging
BLNK
$87.9M
$11K ﹤0.01%
400
FVRR icon
441
Fiverr
FVRR
$339M
$11K ﹤0.01%
61
INCY icon
442
Incyte
INCY
$24.4B
$11K ﹤0.01%
165
MARA icon
443
Marathon Digital Holdings
MARA
$3.9B
$11K ﹤0.01%
343
+59
+21% +$1.92K
TWOU
444
DELISTED
2U Inc
TWOU
$11K ﹤0.01%
11
+2
+22% +$2.34K
ATEX icon
445
Anterix
ATEX
$1.94B
$10K ﹤0.01%
162
RARE icon
446
Ultragenyx Pharmaceutical
RARE
$2.55B
$10K ﹤0.01%
115
VUZI icon
447
Vuzix
VUZI
$224M
$10K ﹤0.01%
924
YELP icon
448
Yelp
YELP
$1.41B
$10K ﹤0.01%
262
ZD icon
449
Ziff Davis
ZD
$1.98B
$10K ﹤0.01%
84
ASXC
450
DELISTED
Asensus Surgical, Inc.
ASXC
$10K ﹤0.01%
5,338

Similar funds

Baillie Gifford & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Baillie Gifford & Co held 509 positions worth $191B, down 6.8% from $205B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Baillie Gifford & Co's Q3 2021 filing shows 38 new, 113 increased, 204 reduced and 17 closed positions. Its largest new stake was Ginkgo Bioworks: 2,275,070 shares worth $1.05B. The largest sale was Alibaba, an estimated $2.87B.

By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Technology.

  • Baillie Gifford & Co's largest Q3 2021 buy was Ginkgo Bioworks: 2,275,070 shares worth $1.05B.
  • Baillie Gifford & Co added most to Peloton Interactive in Q3 2021, an estimated $877M increase.
  • Baillie Gifford & Co's biggest Q3 2021 reduction was Alibaba, cutting an estimated $2.87B.
  • Baillie Gifford & Co fully exited EOG Resources in Q3 2021, selling an estimated $329M.
  • Baillie Gifford & Co's ten largest holdings make up 40% of its $191B portfolio in Q3 2021.
  • Baillie Gifford & Co opened 38 new positions and closed 17 in Q3 2021.
  • Baillie Gifford & Co's portfolio value fell 6.8% quarter-over-quarter to $191B.

Based on Baillie Gifford & Co's 13F filing for Q3 2021, filed 19 Oct 2021.